ANI Pharmaceuticals
- Pharmaceutical Preparations
- Baudette, Minnesota
Compensation history
Top executives at ANI Pharmaceuticals received an average of $2M per person in annual compensation from 2006 to 2021.
Average pay of disclosed executives at ANI Pharmaceuticals
By year
- 2021
NL$7MNikhil LalwaniPresident and Chief Executive OfficerSC$3MStephen P. CareySenior Vice President, Finance and Chief Financial OfficerJM$2MJames G. MarkenSenior Vice President, Operations and Product DevelopmentCM$2MChristopher K. MutzHead of Rare DiseaseOG$2MOri GutwergSenior Vice President, Generics- 2020
NL$4MNikhil LalwaniPresident and Chief Executive OfficerSC$3MStephen P. CareySenior Vice President, Finance and Chief Financial OfficerRS$3MRobert SchrepferFormer Senior Vice President, New Business Development and Specialty SalesJM$2MJames G. MarkenSenior Vice President, Operations and Product DevelopmentPW$962KPatrick D. WalshFormer Interim President and Chief Executive OfficerAP$858KArthur S. PrzybylFormer President and Chief Executive Officer- 2019
AP$6MArthur S. PrzybylPresident, Chief Executive Officer and DirectorRS$2MRobert SchrepferSenior Vice President, New Business Development and Specialty SalesSC$2MStephen P. CareyVice President, Finance and Chief Financial OfficerJM$1MJames G. MarkenSenior Vice President, Operations and Product Development
Executives
We found 12 executives who work or worked at ANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019
About ANI Pharmaceuticals
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address210 Main Street West, Baudette, Minnesota 56623
- Phone2186343500
- Fiscal year endDecember 31
- Former names
- BIOSANTE PHARMACEUTICALS INCUntil July 17, 2013
- BEN ABRAHAM TECHNOLOGIES INCUntil December 22, 1999
Source: SEC filings on March 25, 2022, April 29, 2021, April 23, 2020, April 4, 2019, April 6, 2018, April 6, 2017, April 11, 2014, and April 27, 2009.